Hiromitsu Asashima
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (20)
Year:
2026
Objectives Rituximab (RTX) is a key treatment for ANCA-associated vasculitis (AAV), but RTX-induced acute thrombocytopenia (RIAT) remains a concern. We aimed to evaluate the risk and risk factors of RIAT in patients with AAV undergoing RTX induction therapy. Methods Patients with new-onset microscopic polyangiitis or granulomatosis with polyangiitis who received RTX in a nationwide multicentre registry in Japan were included. RIAT was defined by platelet count reductions within 28 days post-RTX. Risk factors for RIAT were identified by using logistic regression with stepwise selection, and prediction models were developed. Model performance was assessed using C-statistics. Results Among 175 patients with AAV receiving RTX, RIAT occurred in 35.4% of them. Diabetes mellitus (odds ratio [OR] = 4.96), cardiac disease (OR = 3.57), low platelet count (OR = 1.04 per 104/μl decrease), increased serum creatinine (OR = 1.44 per 1 mg/dl increase), low albumin (OR = 2.33 per 1 g/dl decrease), and high KL-6 (OR = 1.09 per 100 U/ml increase) were identified as significant predictors. A predictive model incorporating these factors achieved a C-statistic of 0.817. Conclusion RIAT is a frequent complication of RTX induction in patients with AAV, with diabetes mellitus and cardiac disease being strong risk factors. Our predictive model enables risk assessment for RIAT, allowing clinicians to optimize treatment strategies.
Year:
2026
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple organ involvement. It is known that cytokines produced from activated CD4+ T cells play a pivotal role in the development of SLE; however, the details of pathological processes remain unclear. The purpose of this study is to elucidate the role of activated CD4+ T cells on the pathogenesis of lupus using SLE murine models induced by toll like receptor 7 agonist imiquimod (IMQ). Lupus was induced in wild-type (WT) and interferon γ (IFNγ)-deficient (IFNγ−/−) mice by topical IMQ treatment. Splenic T and B cell subsets were analyzed by flow cytometry. CD4+ T cells and B cells were isolated for co-culture to assess B cell differentiation and IgG production. Comprehensive lupus-like phenotypes were evaluated. Single-cell RNA sequencing (scRNA-seq) was performed to characterize IFNγ-associated cellular and molecular pathways. IMQ treatment increased IFNγ-producing CD4+ T cells, along with Tfh cells, Tph cells, age-associated B cells, and plasma cells in WT mice. CD4+ T cells from IMQ-treated WT mice promoted B-cell differentiation and IgG production in co-culture assays. In IFNγ−/− mice, lupus-like phenotypes were significantly attenuated, and co-cultured B cells showed reduced differentiation and IgG production. Single-cell RNA sequencing revealed that IFNγ plays a critical role in promoting B cell differentiation and autoantibody production. IFNγ derived from activated CD4+ T cells plays a critical role in driving B-cell differentiation and promoting autoantibody production in IMQ-induced lupus.
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Objective To clarify T/B cell-specific gene expression patterns using RNA-Seq in IgG4-related disease (IgG4-RD). Methods Pathologically confirmed submandibular gland (SMG) (n = 3) and peripheral blood mononuclear cells (PBMC) (n = 4) from four treatment-naïve patients with definite IgG4-RD, as well as PBMCs from primary Sjögren syndrome (pSS) (n = 3) and healthy controls (HCs) (n = 3), were collected, and subsequently Pan T and CD19+ B cells were sorted. We conducted RNA sequencing to compare the gene expressions of Pan T and CD19+ B cells in SMGs and PBMCs in IgG4-RD or IgG4-RD versus pSS and HCs in PBMCs. Ingenuity pathway analysis (IPA) and qPCR validation were performed for differentially expressed genes (DEGs). Results Principal component analysis (PCA) results showed the gene expression patterns of Pan T and CD19+ B cells derived from SMGs differed from those derived from PBMCs in IgG4-RD. However, the gene expression patterns of Pan T and CD19+ B cells derived from PBMCs were not clustered between groups. A total of 214 upregulated and 50 downregulated DEGs in Pan T cells and 630 upregulated and 109 downregulated DEGs in CD19+ B cells were identified in SMGs compared with PBMCs in IgG4-RD. The upregulated DEGs in SMGs of IgG4-RD included cytokines, chemokines, and transcription regulators. IPA for these DEGs clarified immune system-related pathways were positively regulated in SMGs compared with PBMCs in IgG4-RD. Quantitative PCR validated significantly increased mRNA expression of IL-21 and EGR2 by Pan T cells in SMGs compared with PBMCs of IgG4-RD. Conclusion RNA-Seq clarified the DEGs of Pan T and CD19+ B cells from SMGs in comparison with PBMCs, which might contribute to the pathogenesis of IgG4-RD.
Year:
2026
Coronavirus disease 2019 (COVID-19) poses significant risks for solid organ transplant recipients, who have atypical but poorly characterized immune responses to infection. We aim to understand the host immunologic and microbial features of COVID-19 in transplant recipients by leveraging a prospective multicenter cohort of 86 transplant recipients age- and sex-matched with 172 non-transplant controls. We find that transplant recipients have higher nasal SARS-CoV-2 viral abundance and impaired viral clearance, and lower anti-spike IgG levels. In addition, transplant recipients exhibit decreased plasmablasts and transitional B cells, and increased senescent T cells. Blood and nasal transcriptional profiling demonstrate unexpected upregulation of innate immune signaling pathways and increased levels of several proinflammatory serum chemokines. Severe disease in transplant recipients, however, is characterized by a less robust induction of pro-inflammatory genes and chemokines. Together, our study reveals distinct immune features and altered viral dynamics in solid organ transplant recipients.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Collaborators (40)
Holden T. Maecker
Stanford University School of Medicine
Suzanna Chak
University of California, San Francisco
Elsio Wunder
Assistant Professor
University of Connecticut
Slim Fourati
Assistant Professor
Northwestern University Feinberg School of Medicine
Bali Pulendran
Emory University
Justin Rousseau
Associate Professor
University of Texas Southwestern Medical Center
Samuel Yang
Faculty
Stanford University
Mehmet Saluvan
Sr. Staff Scientist
Boston Children's Hospital
Yoshia Miyawaki
Special-Appointment Assistant Professor
Okayama Daigaku
Joann Diray Arce
Assistant Professor
Boston Children's Hospital
Albert Ko
Professor of Medicine
Yale University
Kazushi Maruo
Associate professor
University of Tsukuba
Alvin Kho
Assistant Professor
Harvard University
Ramin Salehi-Rad
UCLA
Catherine Blish
Association Professor
Stanford University School of Medicine
Akiko Iwasaki
Professor
Yale University School of Medicine
Scott Brakenridge
Professor
University of Washington
Farrah Kheradmand
Professor
Baylor College of Medicine
Michael Wilson
Professor
University of California, San Francisco
Isao Matsumoto
Professor
University of Tsukuba
Cole Maguire
University of Texas at Austin
Harm van Bakel
Associate Professor
Icahn School of Medicine at Mount Sinai
三木 春香
Associate Professor
University of Tsukuba
Al Ozonoff
Associate Professor
Harvard University
Linda N. Geng
Stanford University
John Greenland
Associate Professor
UCSF Medical Center
Toshiko Ito-Ihara
Specially Appointed Professor
Kyoto Prefectural University of Medicine
Lekshmi Santhosh
Associate Professor
University of California
Aleksandra Leligdowicz
Assistant Professor
University of Western Ontario
anil sapru
Professor
University of California
Mary Ann Comunale
Assistant Professor
Drexel University College of Medicine
Angela Rogers
Professor
University of Texas Southwestern Medical Center
Masaru Shimizu
Specially Appointed Lecturer
University of Tsukuba
George A Yendewa
Assistant Professor
Case Western Reserve University School of Medicine
Nathan Grubaugh
Associate Professor
Yale School of Public Health
Yuya Kondo
Lecturer
University of Tsukuba
Michele Kutzler
Professor of Medicine and Microbiology and Immunology
Drexel University
Boryana Petrova
Head of Research Metabolomics
Medical University of Vienna
Erin Scherer
Associate Professor
Emory University
Edward Vincent S. Faustino
Professor of Pediatrics (Critical Care)
Yale University School of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.